NDC 73604-914
Arcalyst 160 mg per 2 mL injection, powder, lyophilized, for solution
On the label: Kiniksa Pharmaceuticals (UK), Ltd..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Jubilant HollisterStier LLC | Spokane, WA, United States | Makes it and tests it | No problems foundMar 5, 2021 · 13 inspections, 1 with FDA action |
| Kiniksa Pharmaceuticals (UK), Ltd. | London, United Kingdom | Makes it | Not inspected on record |
| Regeneron Pharmaceuticals, Inc. | Rensselaer, NY, United States | Makes the active ingredient and tests it | Problems found, fixed voluntarilyMar 22, 2024 · 10 inspections |
| Almac Pharma Services LLC | Audubon, PA, United States | Packages it | Problems found, fixed voluntarilyAug 22, 2025 · 4 inspections |
| Kiniksa Pharmaceuticals (UK), Ltd., London (UK), Zweigniederlassung Zug | Zug, Switzerland | Tests it | Not inspected on record |
| Packaging Coordinators, LLC | Philadelphia, PA, United States | Packages it | Problems found, fixed voluntarilyJan 31, 2025 · 6 inspections |
Product details
- Generic drug
- Rilonacept: every company that makes it
- Form
- injection, powder, lyophilized, for solution, subcutaneous
- Strength
- 160 mg per 2 mL
- Approval
- BLA BLA125249
- On the market since
- Feb 27, 2008
- Package NDCs
73604-914-0173604-914-04- Official label
- DailyMed (National Library of Medicine), updated Dec 16, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?